Tara Bancroft
Stock Analyst at TD Cowen
(4.80)
# 543
Out of 5,136 analysts
306
Total ratings
48.2%
Success rate
22.1%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tara Bancroft
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TGTX TG Therapeutics | Reiterated: Buy | $75 | $62.76 | +19.50% | 15 | Nov 9, 2026 | |
| MLYS Mineralys Therapeutics | Reiterated: Buy | n/a | $14.53 | - | 3 | Nov 5, 2026 | |
| PCVX Vaxcyte | Reiterated: Buy | $75 | $61.61 | +21.73% | 17 | Nov 5, 2026 | |
| XNCR Xencor | Reiterated: Buy | n/a | $35.40 | - | 14 | Nov 5, 2026 | |
| GERN Geron | Reiterated: Buy | $3 | $0.9419 | +218.51% | 22 | Nov 4, 2026 | |
| CELC Celcuity | Reiterated: Buy | $145 | $60.57 | +139.39% | 15 | Oct 21, 2026 | |
| INCY Incyte | Reiterated: Buy | $140 | $120.27 | +16.40% | 1 | Oct 21, 2026 | |
| PTGX Protagonist Therapeutics | Reiterated: Buy | $155 → $160 | $124.83 | +28.17% | 18 | Oct 21, 2026 | |
| NBTX Nanobiotix | Reiterated: Buy | n/a | $28.54 | - | 4 | Sep 25, 2026 | |
| RCUS Arcus Biosciences | Initiated Coverage: Buy | n/a | $16.86 | - | 1 | Sep 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $9.28 | - | 1 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $20 → $4 | $0.3076 | +1,200.39% | 4 | Sep 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.14 | - | 14 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $2.17 | - | 15 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $9.32 | - | 13 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.1451 | - | 12 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $12 | $5.65 | +112.39% | 1 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $2.16 | - | 3 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $3.01 | - | 13 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $50 → $60 | $28.10 | +113.52% | 24 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $110 → $103 | $101.72 | +0.77% | 21 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $6.01 | +232.78% | 24 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $3.18 | - | 13 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $76.59 | - | 14 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $1.46 | - | 1 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20.00 | $13.24 | +51.11% | 16 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.8631 | n/a | 2 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $3.20 | n/a | 3 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $13.50 | n/a | 2 | Jul 26, 2024 |
TG Therapeutics
Nov 9, 2026
Reiterated: Buy
Price Target: $75
Current: $62.76
Upside: +19.50%
Mineralys Therapeutics
Nov 5, 2026
Reiterated: Buy
Price Target: n/a
Current: $14.53
Upside: -
Vaxcyte
Nov 5, 2026
Reiterated: Buy
Price Target: $75
Current: $61.61
Upside: +21.73%
Xencor
Nov 5, 2026
Reiterated: Buy
Price Target: n/a
Current: $35.40
Upside: -
Geron
Nov 4, 2026
Reiterated: Buy
Price Target: $3
Current: $0.9419
Upside: +218.51%
Celcuity
Oct 21, 2026
Reiterated: Buy
Price Target: $145
Current: $60.57
Upside: +139.39%
Incyte
Oct 21, 2026
Reiterated: Buy
Price Target: $140
Current: $120.27
Upside: +16.40%
Protagonist Therapeutics
Oct 21, 2026
Reiterated: Buy
Price Target: $155 → $160
Current: $124.83
Upside: +28.17%
Nanobiotix
Sep 25, 2026
Reiterated: Buy
Price Target: n/a
Current: $28.54
Upside: -
Arcus Biosciences
Sep 16, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $16.86
Upside: -
Sep 9, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $9.28
Upside: -
Sep 1, 2026
Downgraded: Hold
Price Target: $20 → $4
Current: $0.3076
Upside: +1,200.39%
Aug 13, 2026
Reiterated: Hold
Price Target: n/a
Current: $1.14
Upside: -
Aug 13, 2026
Reiterated: Hold
Price Target: n/a
Current: $2.17
Upside: -
Aug 12, 2026
Reiterated: Buy
Price Target: n/a
Current: $9.32
Upside: -
Aug 12, 2026
Reiterated: Buy
Price Target: n/a
Current: $0.1451
Upside: -
Aug 11, 2026
Initiated Coverage: Buy
Price Target: $12
Current: $5.65
Upside: +112.39%
Aug 10, 2026
Reiterated: Hold
Price Target: n/a
Current: $2.16
Upside: -
Aug 6, 2026
Reiterated: Hold
Price Target: n/a
Current: $3.01
Upside: -
Aug 5, 2026
Rated: Buy
Price Target: $50 → $60
Current: $28.10
Upside: +113.52%
Aug 3, 2026
Downgraded: Hold
Price Target: $110 → $103
Current: $101.72
Upside: +0.77%
Aug 3, 2026
Reiterated: Buy
Price Target: $20
Current: $6.01
Upside: +232.78%
Jul 30, 2026
Reiterated: Buy
Price Target: n/a
Current: $3.18
Upside: -
Jul 30, 2026
Reiterated: Buy
Price Target: n/a
Current: $76.59
Upside: -
Jun 15, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $1.46
Upside: -
Feb 19, 2026
Reiterated: Buy
Price Target: $20.00
Current: $13.24
Upside: +51.11%
Mar 14, 2025
Rated: Hold
Price Target: n/a
Current: $0.8631
Upside: n/a
Aug 9, 2024
Rated: Buy
Price Target: n/a
Current: $3.20
Upside: n/a
Jul 26, 2024
Downgraded: Hold
Price Target: n/a
Current: $13.50
Upside: n/a